The EU Pharmaceutical Legislation Reform: Impact on the API Industry
Tuesday | 21 October
Highlights
Practical assistance and experiences how to introduce a new intermediate manufacturer and how to deal with a new impurity in your API! Get the information from our speakers about the quality and regulatory perspective of:
- Important changes for the API industry caused by the EU Pharmaceutical Legislation Reform
- Handling revisions of CEPs at EDQM
- API Changes: Validation and Implementation
Objectives
This ECA course provides an overview of the EU Pharmaceutical Legislation Reform and its impact on the API industry – from a regulatory and GMP point of view. During interactive sessions you will get to know:
- Which GMP and regulatory aspects have to be considered to successfully submit a change
- How to introduce a new intermediate manufacturer
- How to deal with a new impurity in your API and what actions have to be taken
- How to define critical quality attributes, critical process parameters, critical material attributes and an accurate control strategy
Furthermore, you will have the opportunity to reach clarification on ambiguous issues by bringing your questions up for discussion during the so-called break-out sessions.
This ECA course ideally complements the following 28th APIC/CEFIC Global GMP & Regulatory API Conference.
Background
The API world is changing rapidly. Nowadays, changes are a daily business in the API industry. Companies are struggling with the challenge of how to implement the new regulations and requirements caused by e.g. reforms of the guidelines. To ensure the quality of their products throughout their life cycles, API changes need to be validated, submitted and implemented successfully. On the one hand, the theoretical obligations need to be considered and well known, while on the other hand the practical implementation needs to be beneficial and manageable in day-to-day API work.
Hot topics are presented in three lectures and two case studies. Additionally, you will have the chance to discuss your own topics with the speakers during the break-out sessions. Besides explaining the requirements of the guidelines of e.g. the revised variations guideline, for the respective themes, the speakers will share their approaches, experiences and best practices on these API related quality and regulatory topics.
Target Audience
This ECA course is designed for all persons involved in the manufacture of APIs, especially for persons from production, quality control, quality assurance, technical and regulatory affairs departments. We are also addressing interested parties from the pharmaceutical industry as well as GMP inspectorates.
Programm
An Overview of the EU Pharmaceutical Legislation Reform
- Background of the revision
- Key elements of the proposal
- Important Changes for the API industry
- the revision of the variations guideline
- the introduction of the API certificate
Handling Revisions of CEPs at EDQM
- Impact of the EU guideline on classification of variations on the EDQM guideline for revisions of CEPs
- Key aspects to submit successfully a change
API Changes: Validation and Implementation
- Defining critical quality attributes, critical process parameters, critical material attributes and accurate control strategy
- Eudralex Vol 4 Annex 15 on process validation
- Implementation steps and performance monitoring
- Use PV and scientific knowledge to implement Lean GMP systems
Break-out Sessions
Take advantage of the experiences of our speakers and send us your questions and real-life scenarios/challenges prior to the ECA course. Your questions and examples are appreciated and will be answered as comprehensively as possible by the experts during the break-out sessions and Q&A sessions.
